Raynaud DiseaseScleroderma, SystemicProstaglandins EAdultFemaleA forty year old female presented with severe Raynaud's phenomenon in her hands and feet associated with scleroderma. After assessment of hand and
This medicine may cause slow growth. If your child is using this medicine, the doctor will need to keep track of your child's height and weight. This medicine may causeRaynaud's phenomenon, which is a problem with blood circulation in the fingers or toes. Tell your doctor if you have ti...
If your child is using this medicine, the doctor will need to keep track of your child's height and weight. This medicine may cause Raynaud's phenomenon, which is a problem with blood circulation in the fingers or toes. Tell your doctor if you have tingling or pain, a cold feeling, ...
Linden D. Severe Raynaud’s phenomenon associated with interferon-beta treatment for multiple sclerosis. Lancet. 1998;352(9131):878–9.Linden D: Severe Raynaud’s phenomenon associated with interferon beta treatment for multiple sclerosis . Lancet 1998, 352 :878–879. View Article...
Raynaud's phenomenon is a symptom complex manifested as intermittent fingertip ischemia caused by cold or other sympathetic drivers.Secondary Raynaud's phenomenon is often more severe and could even lead to finger ulceration,making it particularly complicated to treat.We describe a case of severe ...
Allen JA, O'Reilly MJ (1981) Treatment of severe Raynaud's phenomenon with prostaglandin E 1 . Ir J Med Sci 150:190–191Allen, JA, O'Reilly, MJ (1981) Treatment of severe Raynaud's phenomenon with prostaglandin E1. Ir J Med Sci 150: pp. 190-191...
Neuhauser B et al (2001) Clinical and objective data on spinal cord stimulation for the treatment of severe raynaud’s phenomenon. Am Surg 67:1096–1097Neuhauser, B,Perkmann, R,Klingler, P.J,Giacomuzzi, S,Kofler, A,Fraedrich, G.Clinical and objective data on spinal cord stimulation for ...
Hafner J, Della Santa D, Zuber C, Christen Y, Bounameaux H. Digital sympathectomy (microarteriolysis) in the treatment of severe Raynaud's phenomenon secondary to systemic sclerosis. Br J Dermatol 1997;137:1011-31.Hafner J, Della SD, Zuber C, Christen Y, Bounameaux H. Digital sympath...
Linden D. Severe Raynaud’s phenomenon associated with interferon-beta treatment for multiple sclerosis. Lancet. 1998;352(9131):878–9.Linden D: Severe Raynaud’s phenomenon associated with interferon beta treatment for multiple sclerosis . Lancet 1998, 352 :878–879. View Article...
Inpharma Weekly -doi:10.2165/00128413-200012540-00030NoneSpringer International PublishingInpharma Weekly